Skip to content

Deep brain stimulation for obsessive-compulsive disorder

Deep brain stimulation for obsessive-compulsive disorder - DBS for OCD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50163
Enrollment
70
Registered
2019-10-02
Start date
2020-03-05
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obsessive-compulsive disorder

Interventions

The patients are treated with deep brain stimulation.

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: We will include patients who meet the following inclusion criteria: - Obsessive compulsive disorder according to DSM-5 criteria - At least one of the following conditions is met: 1) Y-BOCS score >= 28; 2) Y--BOCS >= 14 in case of solely obsessions or compulsions; 3) Suffering from obsessions or compulsions for at least 8 hours a day (i.e. a score of 4 on item 1 or item 6 of the Y-BOCS) - Treatment refractoriness is defined as failure of all of the following: 1) at least 2 different types of SSRI*s; 2) clomipramine; 3) addition of an antipsychotic to either an SSRI or clomipramine; 4) an adequate trial of cognitive-behavorial therapy given by a therapist who has experience with OCD; all treatments should be given at therapeutic dosages for adequate duration. On clinical grounds, exceptions to this definition are allowed, but only after consultation with the coordinating center. - Age: 18 years or older - Motivated and capable to make the frequent visits to the outpatient clinic, which are necessary for parameter optimization and the CBT. - Mentally capable to understand the consequences of the procedure and make his or her own choice without coercion

Exclusion criteria

Exclusion criteria: - Primary diagnosis in psychotic spectrum - Unstable multiple sclerosis (MS) - Acute brain damage (eg. recent hemorrhage or stroke) - General contraindications to have surgery

Design outcomes

Primary

MeasureTime frame
Change in obsessive-compulsive symptomes (measured as a change of Y-BOCS score compared to baseline)

Secondary

MeasureTime frame
Depressive symptoms (measured with the Hamilton Depression Rating Scale) Adverse events DBS settings Medication use

Countries

Netherlands

Contacts

Public ContactR.J.T. Mocking

Amsterdam UMC

j.f.bertad@amsterdamumc.nl020-8913500

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)